Cost and disease burden of Dengue in Cambodia
<p>Abstract</p> <p>Background</p> <p>Dengue is endemic in Cambodia (pop. estimates 14.4 million), a country with poor health and economic indicators. Disease burden estimates help decision makers in setting priorities. Using recent estimates of dengue incidence in Cambo...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2010-08-01
|
| Series: | BMC Public Health |
| Online Access: | http://www.biomedcentral.com/1471-2458/10/521 |
| _version_ | 1818569888176799744 |
|---|---|
| author | Beauté Julien Vong Sirenda |
| author_facet | Beauté Julien Vong Sirenda |
| author_sort | Beauté Julien |
| collection | DOAJ |
| description | <p>Abstract</p> <p>Background</p> <p>Dengue is endemic in Cambodia (pop. estimates 14.4 million), a country with poor health and economic indicators. Disease burden estimates help decision makers in setting priorities. Using recent estimates of dengue incidence in Cambodia, we estimated the cost of dengue and its burden using disability adjusted life years (DALYs).</p> <p>Methods</p> <p>Recent population-based cohort data were used to calculate direct and productive costs, and DALYs. Health seeking behaviors were taken into account in cost estimates. Specific age group incidence estimates were used in DALYs calculation.</p> <p>Results</p> <p>The mean cost per dengue case varied from US$36 - $75 over 2006-2008 respectively, resulting in an overall annual cost from US$3,327,284 in 2008 to US$14,429,513 during a large epidemic in 2007. Patients sustain the highest share of costs by paying an average of 78% of total costs and 63% of direct medical costs. DALY rates per 100,000 individuals ranged from 24.3 to 100.6 in 2007-2008 with 80% on average due to premature mortality.</p> <p>Conclusion</p> <p>Our analysis confirmed the high societal and individual family burden of dengue. Total costs represented between 0.03 and 0.17% of Gross Domestic Product. Health seeking behavior has a major impact on costs. The more accurate estimate used in this study will better allow decision makers to account for dengue costs particularly among the poor when balancing the benefits of introducing a potentially effective dengue vaccine.</p> |
| first_indexed | 2024-12-14T06:53:35Z |
| format | Article |
| id | doaj.art-27b284711ab345eaacc2f3f747a1c681 |
| institution | Directory Open Access Journal |
| issn | 1471-2458 |
| language | English |
| last_indexed | 2024-12-14T06:53:35Z |
| publishDate | 2010-08-01 |
| publisher | BMC |
| record_format | Article |
| series | BMC Public Health |
| spelling | doaj.art-27b284711ab345eaacc2f3f747a1c6812022-12-21T23:12:48ZengBMCBMC Public Health1471-24582010-08-0110152110.1186/1471-2458-10-521Cost and disease burden of Dengue in CambodiaBeauté JulienVong Sirenda<p>Abstract</p> <p>Background</p> <p>Dengue is endemic in Cambodia (pop. estimates 14.4 million), a country with poor health and economic indicators. Disease burden estimates help decision makers in setting priorities. Using recent estimates of dengue incidence in Cambodia, we estimated the cost of dengue and its burden using disability adjusted life years (DALYs).</p> <p>Methods</p> <p>Recent population-based cohort data were used to calculate direct and productive costs, and DALYs. Health seeking behaviors were taken into account in cost estimates. Specific age group incidence estimates were used in DALYs calculation.</p> <p>Results</p> <p>The mean cost per dengue case varied from US$36 - $75 over 2006-2008 respectively, resulting in an overall annual cost from US$3,327,284 in 2008 to US$14,429,513 during a large epidemic in 2007. Patients sustain the highest share of costs by paying an average of 78% of total costs and 63% of direct medical costs. DALY rates per 100,000 individuals ranged from 24.3 to 100.6 in 2007-2008 with 80% on average due to premature mortality.</p> <p>Conclusion</p> <p>Our analysis confirmed the high societal and individual family burden of dengue. Total costs represented between 0.03 and 0.17% of Gross Domestic Product. Health seeking behavior has a major impact on costs. The more accurate estimate used in this study will better allow decision makers to account for dengue costs particularly among the poor when balancing the benefits of introducing a potentially effective dengue vaccine.</p>http://www.biomedcentral.com/1471-2458/10/521 |
| spellingShingle | Beauté Julien Vong Sirenda Cost and disease burden of Dengue in Cambodia BMC Public Health |
| title | Cost and disease burden of Dengue in Cambodia |
| title_full | Cost and disease burden of Dengue in Cambodia |
| title_fullStr | Cost and disease burden of Dengue in Cambodia |
| title_full_unstemmed | Cost and disease burden of Dengue in Cambodia |
| title_short | Cost and disease burden of Dengue in Cambodia |
| title_sort | cost and disease burden of dengue in cambodia |
| url | http://www.biomedcentral.com/1471-2458/10/521 |
| work_keys_str_mv | AT beautejulien costanddiseaseburdenofdengueincambodia AT vongsirenda costanddiseaseburdenofdengueincambodia |